Edwards Lifesciences (EW) Revenue (2009 - 2026)

Edwards Lifesciences' Revenue history runs 18 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• In Q1 2026, Revenue rose 16.7% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $6.3 billion (up 14.15% YoY), while the FY2025 annual figure was $6.1 billion, up 11.55% from the prior year.
• Revenue was $1.6 billion for Q1 2026 at Edwards Lifesciences, up from $1.6 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.6 billion in Q1 2026 to a low of $429.9 million in Q4 2022.
• Historically, Revenue has averaged $1.3 billion across 5 years, with a median of $1.4 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Revenue plunged 67.67% in 2022, then jumped 194.58% in 2023.
• A 5-year view of Revenue shows it stood at $429.9 million in 2022, then surged by 194.58% to $1.3 billion in 2023, then climbed by 9.43% to $1.4 billion in 2024, then gained by 13.26% to $1.6 billion in 2025, then increased by 5.03% to $1.6 billion in 2026.
• The last three Revenue figures came in at $1.6 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.